New York State’s Prescription Monitoring Program (PMP): What Prescribers Need to Know About Ensuring Their Patients’ Safety
Click to Enlarge
Most prescribers in New York State are legally required to consult the Prescription Monitoring Program (PMP) Registry every time they write a prescription for Schedule II, III and IV controlled substances. The New York State PMP has been in place since 2013. It is time for all prescribers and their designees to update their knowledge of best practices and requirements for using the PMP properly and consistently. Learn more about any changes or updates to the PMP and refresh your knowledge of how best to fully utilize this mandatory and effective system. Frank Dowling, MD will serve as faculty for this webinar. Register now. Be sure to note the option on the registration page to submit questions prior to the webinar.
Educational Objectives are:
- Increase prescriber awareness of the continued opioid epidemic
- Describe the benefits of the New York State (NYS) Prescription Monitoring Program (PMP) Registry and how to use it effectively as a tool to monitor patients’ prescription history
- Explain NYS Public Health Law related to NYS PMP Registry and how it impacts prescribers
View the New York State Bureau of Narcotics Enforcement educational materials and registration brochure:
Contact Melissa Hoffman at [email protected] for additional information.
The Medical Society of the State of New York is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this live activity for a maximum of 1.0 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
